Good news for Estonians: tick-borne encephalitis vaccine intervals extended to 10 years

New guidelines allow up to ten years between tick-borne encephalitis booster shots, making vaccination schedules more convenient. Additionally, a vaccine against Lyme disease — which causes severe pain — is expected to reach the market soon.

Estonians who have been vaccinated against tick-borne encephalitis can now wait up to ten years between booster doses, according to updated vaccination guidelines. The change is welcome news for those who previously had to keep track of shorter intervals to maintain protection against the serious neurological disease spread by ticks.

Tick-borne encephalitis remains a significant health concern in Estonia, where forests and green spaces make tick exposure common during warmer months. The encephalitis virus can cause inflammation of the brain and spinal cord, with potentially severe long-term consequences. Vaccination has long been the most effective preventive measure, and simplifying the booster schedule is expected to improve compliance among the population.

In addition to the updated encephalitis vaccine schedule, medical experts point to promising developments on the horizon for another tick-transmitted illness. A vaccine targeting Lyme disease — also known as borreliosis — is expected to reach the market in the coming years. Lyme disease can cause debilitating joint pain, fatigue, and neurological symptoms, and currently has no approved preventive vaccine available to the public.

The potential arrival of a Lyme disease vaccine would mark a significant step forward in tick-borne illness prevention. Together with the more flexible encephalitis vaccination schedule, these developments could substantially reduce the burden of tick-related health problems in Estonia and across the Baltic region.